OT
OTLC
Oncotelic Therapeutics, Inc.
$0.0500
0.00%
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
May 13, 2026
earnings_calendar
OTLC Q1 2026 Earnings Scheduled — 2026-05-13
May 5, 2026
SEC
Oncotelic Therapeutics completed a multi-step transaction (May 1, 2026) contributing its patent portfolio to Lunai Biowo
8-K — Impact 5/10
Apr 16, 2026
SEC
Oncotelic Therapeutics reported a $249 million net income for FY 2025, driven by a $365.4 million non-cash gain from the
8-K — Impact 7/10
Apr 2, 2026
SEC
Oncotelic Therapeutics entered into a joint development, manufacturing, and licensing agreement with TechForce Robotics
8-K — Impact 4/10
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
8-K
5/10
Oncotelic Therapeutics completed a multi-step transaction (May 1, 2026) contributing its patent portfolio to Lunai Biowo
May 5, 2026
BULLISH
8-K
7/10
Oncotelic Therapeutics reported a $249 million net income for FY 2025, driven by a $365.4 million non-cash gain from the
Apr 16, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 5.3/10.
NEUTRAL
8-K
5/10
Oncotelic Therapeutics completed a multi-step transaction (May 1, 2026) contributing its patent port
May 5, 2026
BULLISH
8-K
7/10
Oncotelic Therapeutics reported a $249 million net income for FY 2025, driven by a $365.4 million no
Apr 16, 2026
NEUTRAL
8-K
4/10
Oncotelic Therapeutics entered into a joint development, manufacturing, and licensing agreement with
Apr 2, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2023-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% | |
| May 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 13, 2026
earnings_calendar
OTLC Q1 2026 Earnings Scheduled — 2026-05-13
Apr 15, 2026
earnings_calendar
OTLC Q4 2025 Earnings After Market Close — 2026-04-15
Apr 13, 2026
earnings_calendar
OTLC Q4 2025 Earnings After Market Close — 2026-04-13